Welcome to LookChem.com Sign In|Join Free

CAS

  • or

40258-99-9

Post Buying Request

40258-99-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

40258-99-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 40258-99-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,0,2,5 and 8 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 40258-99:
(7*4)+(6*0)+(5*2)+(4*5)+(3*8)+(2*9)+(1*9)=109
109 % 10 = 9
So 40258-99-9 is a valid CAS Registry Number.

40258-99-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(chlorocarbonyl)cyclopropanecarboxylic acid

1.2 Other means of identification

Product number -
Other names Cyclopropanecarboxylic acid, 1-(chlorocarbonyl)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:40258-99-9 SDS

40258-99-9Downstream Products

40258-99-9Relevant articles and documents

TREATMENT OF CANCER WITH ANTI-OX40 ANTIBODIES AND MULTI-KINASE INHIBITORS

-

Paragraph 0089-0091, (2021/05/29)

The present disclosure provides methods of treating cancer with non-competitive, agonist anti-OX40 antibodies and antigen-binding fragments thereof that bind to human OX40 (ACT35, CD134, or TNFRSF4), in combination with a multi-kinase inhibitor.

Preparation method of cabozantinib nitrogen oxide impurity

-

Paragraph 0025-0026; 0036-0037, (2020/08/27)

The invention discloses a preparation method of a cabozantinib nitrogen oxide impurity. The method comprises the following steps: preparation of an intermediate 1, preparation of 4-chloro-6, 7-dimethoxyquinoline, preparation of an intermediate 2, and prep

METHOD OF PREPARING FLUORINE-18 LABELED CABOZANTINIB AND ITS ANALOGS

-

Paragraph 00102; 00103, (2016/03/29)

The present invention relates to a method of preparing Cabozantinib (Cyclopropane- 1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenylo]amide (4-fluoro- phenyl)amide) and 18F labeled Cabozantinib.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 40258-99-9